pembrolizumab plus chemotherapy for esophageal cancer: keynote-590
Published 3 years ago • 1.4K plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
8:45
keynote-590: pembrolizumab plus chemotherapy for advanced oesophageal cancer
-
2:11
pembrolizumab vs. chemo in first-line mcrc
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
1:21
dr. shah on the rationale for the keynote-590 trial in esophageal carcinoma
-
4:35
keynote-062: pembrolizumab vs. chemo in 1l advanced gastric cancer
-
6:21
pembrolizumab plus trastuzumab and chemotherapy for her2 metastatic gastric or gastroesophageal...
-
2:25
adjuvant therapy for esophageal cancer
-
3:04
keynote-024 update: pembrolizumab vs platinum-based chemotherapy in nsclc
-
43:05
treatment of esophageal cancer in 2021 | zev a. wainberg, md | professor of medicine, ucla
-
17:28
esophageal cancer with pembrolizumab
-
1:40
keynote-811: trastuzumab chemotherapy with or without pembrolizumab for her2 g/gej cancer
-
0:37
pembrolizumab shows promise for advanced esophageal cancers
-
1:44
unmet needs in chemoradiotherapy for esophageal cancer
-
1:44
chemo-immunotherapy in patients with locally advanced gastroesophageal cancer
-
7:45
pembrolizumab alone or with chemotherapy for advanced gastric/ge junction cancer
-
3:28
keynote-775 subgroup analysis in advanced endometrial cancer
-
3:14
keynote-062 study: pembrolizumab as treatment for advanced gastroesophageal junction and gastric...
-
3:09
rationale-306: asian subgroup of 1l tislelizumab chemo vs chemo alone for esophageal scc
-
2:09
keynote-240: pembrolizumab in advanced hcc